Yes, Reach was about the safety and tolerability of PBT2, but it was also about its effect on amyloid deposition in the brain. Participants were to undergo brain scans to measure PBT2’s effect on amyloid deposits in the brain and effects on increasing brain activity. Cognition effects were being measured using scientifically validated tests (TMTB being one) that measure the type of cognitive problems experienced by prodromal and early Alzheimer’s patients. I wasn't aware that unlike the original 12 months the extension only concentrated on safety.
- Forums
- ASX - By Stock
- Ann: Appendix 4E and Annual Report 2015
Yes, Reach was about the safety and tolerability of PBT2, but it...
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.001(25.0%) |
Mkt cap ! $26.19M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.5¢ | $27.94K | 6.050M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
46 | 57663299 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 56205001 | 43 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
46 | 57663299 | 0.004 |
74 | 84174813 | 0.003 |
19 | 29345125 | 0.002 |
15 | 81865101 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 56205001 | 43 |
0.006 | 17905330 | 28 |
0.007 | 9388861 | 18 |
0.008 | 7693109 | 15 |
0.009 | 4646078 | 9 |
Last trade - 16.10pm 29/03/2024 (20 minute delay) ? |
|
|||||
Last
0.5¢ |
  |
Change
0.001 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
0.5¢ | 0.5¢ | 0.5¢ | 20524121 | ||
Last updated 15.46pm 29/03/2024 ? |
Featured News
ATH (ASX) Chart |